AvePoint CLO Sells 35,000 AVPT Shares Under 10b5-1, Retains 1.19M

AvePoint, Inc. (AVPT) Form 4: Chief Legal Officer & Director Brian Michael Brown disposed of 35,000 common shares on 07/23/2025 at $18.74, generating roughly $656 k in gross proceeds.

Rhea-AI Filing Summary

AvePoint, Inc. (AVPT) Form 4: Chief Legal Officer & Director Brian Michael Brown disposed of 35,000 common shares on 07/23/2025 at $18.74, generating roughly $656 k in gross proceeds. The sale was executed under a Rule 10b5-1 trading plan adopted 12/18/2024, indicating it was pre-scheduled rather than discretionary.

After the transaction Brown still beneficially owns 1,190,443 shares (combining non-RSU stock and vested/unvested RSUs) held directly. No derivative securities were exercised or disposed. Brown continues to serve as both Chief Legal Officer and a Director, preserving substantial equity alignment with shareholders despite the sale. The filing contains no company-level financial data; its relevance is limited to insider-sentiment considerations.

Insights

Securities Analyst

TL;DR: Pre-planned insider sale; modest size vs. 1.19 M stake – neutral market impact.

The 35 k-share sale equals ~3% of Brown’s holdings and under 0.2% of AvePoint’s float, so supply pressure is negligible. Use of a 10b5-1 plan reduces informational asymmetry concerns, suggesting routine diversification rather than a bearish signal. Brown’s remaining 1.19 M shares support continued alignment. I view the filing as informational but not materially price-moving. Insider-selling trends should still be monitored if volume accelerates.

Corporate Governance Expert

TL;DR: Governance-friendly disclosure, but insider selling can raise perception risk.

Transparent reporting and adherence to 10b5-1 best practices mitigate governance red flags. However, any sale by a senior legal officer may be interpreted negatively by some investors, especially absent offsetting open-market buys by other insiders. Given the small fraction sold and remaining sizable stake, I classify the overall governance impact as low, yet perception risk warrants minimal caution.

Insider Trade Summary

Net Seller: 35,000 shares

Net Sell 1 txn

Insider Brown Brian Michael

Role Chief Legal Officer

Sold 35,000 shs ($656K)

Type	Security	Shares	Price	Value
Sale	Common Stock	35,000	$18.74	$656K

Holdings After Transaction: Common Stock — 1,190,443 shares (Direct)

Footnotes (2)

1. F1. The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2024.
2. F2. Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024 and March 18, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AvePoint (AVPT) insider Brian Michael Brown sell on 07/23/2025?

35,000 common shares at $18.74 per share were sold.

How many AvePoint shares does Brown still own after the sale?

He beneficially owns 1,190,443 shares, including vested and unvested RSUs.

Was the transaction part of a Rule 10b5-1 plan?

Yes. The plan was adopted on 12/18/2024, indicating a pre-scheduled sale.

Did the Form 4 report any option exercises or other derivative transactions?

No. No derivative securities were acquired or disposed of in this filing.

What roles does Brian Michael Brown hold at AvePoint?

He is the company’s Chief Legal Officer and a Director.

Does insider selling always signal negative prospects for AVPT?

Not necessarily; pre-planned sales for diversification are common. Investors should monitor volume and compare to total holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/25/2025 - 06:36 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Brown Brian Michael

(Last) (First) (Middle)

C/O AVEPOINT, INC.

901 E BYRD ST, SUITE 900

(Street)

RICHMOND VA 23219

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/23/2025		S		35,000(1)	D	$18.74	1,190,443(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2024.

2. Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024 and March 18, 2025.

	/s/ Brian Michael Brown	07/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.